Liver King TRT Protocol: The Evidence Base Behind Every Compound He Admitted Using

What Liver King Actually Admitted To

In December 2022, Brian Johnson posted a video confirming he had used performance-enhancing drugs while publicly promoting an "ancestral lifestyle" as the sole explanation for his physique. The admission followed leaked emails, first published by fitness YouTuber Derek of More Plates More Dates, that detailed a multi-compound regimen supervised by a coaching service.

The Leaked Protocol

The emails outlined a stack that included testosterone (likely cypionate), human growth hormone (HGH), nandrolone decanoate (Deca-Durabolin), IGF-1, and additional ancillary compounds. The reported cost sat around $11,000 per month. Johnson stated in his December 2022 video: "I lied, and I'm sorry." He did not dispute the specific compounds listed in the leaked correspondence.

Why the Admission Matters Clinically

This case matters beyond celebrity gossip because it exposed a gap between social media physique marketing and pharmacological reality. The Endocrine Society's 2018 guidelines on testosterone therapy explicitly state that testosterone treatment is indicated for men with "pathologic hypogonadism" confirmed by low morning testosterone on two separate occasions, not for physique optimization in eugonadal men 1. Johnson never disclosed a clinical diagnosis.

Testosterone: The Backbone of the Stack

Testosterone replacement therapy (TRT) is the most widely prescribed androgen therapy in men with documented hypogonadism. Standard clinical doses differ dramatically from what physique-focused protocols typically employ.

FDA-Approved TRT Dosing vs. Supraphysiological Use

FDA-approved testosterone cypionate dosing for hypogonadal men ranges from 50 to 400 mg intramuscularly every two to four weeks, titrated to maintain serum testosterone in the mid-normal range (400 to 700 ng/dL) 2. Bodybuilding-oriented protocols commonly exceed 500 mg per week, pushing serum levels well above 1,500 ng/dL. A 2004 study by Bhasin et al. In the American Journal of Physiology demonstrated that muscle cross-sectional area and strength increase in a dose-dependent manner from 25 mg to 600 mg weekly, but adverse effects on HDL cholesterol, hematocrit, and acne also scale with dose 3.

Cardiovascular Risk at High Doses

The TRAVERSE trial (N=5,246), published in the New England Journal of Medicine in 2023, found that standard-dose TRT in hypogonadal men aged 45 to 80 with cardiovascular risk did not increase major adverse cardiovascular events compared to placebo over a mean follow-up of 33 months 4. That finding applies to physiologic replacement. Supraphysiological testosterone, the kind seen in physique protocols, carries different risk. A 2010 observational cohort in the Journal of the American Heart Association linked anabolic steroid use in male weightlifters to a significantly higher prevalence of left ventricular hypertrophy and reduced systolic function 5.

Hematologic Concerns

Testosterone at any dose stimulates erythropoiesis. At supraphysiological levels, hematocrit can climb above 54%, increasing viscosity and thromboembolic risk. The Endocrine Society recommends monitoring hematocrit at 3 to 6 months and then annually during TRT, with dose reduction or phlebotomy if hematocrit exceeds 54% 1.

Human Growth Hormone: Expensive and Narrowly Indicated

HGH is FDA-approved for adult growth hormone deficiency (GHD) confirmed by provocative testing and for AIDS-associated wasting. It is not approved for anti-aging, body composition enhancement, or athletic performance in otherwise healthy adults.

What the Evidence Shows for Body Composition

A 2007 meta-analysis by Liu et al. In the Annals of Internal Medicine pooled 27 studies of HGH in healthy older adults and found that GH therapy increased lean body mass by a mean of 2.0 kg and reduced fat mass by 2.1 kg 6. Those are modest changes. Side effects included edema (reported in 24% of GH-treated participants), arthralgias (30%), and carpal tunnel syndrome (5.3%).

Insulin Resistance and Glucose Dysregulation

Exogenous GH is diabetogenic. Growth hormone opposes insulin action at the hepatic and peripheral level. A 2009 study in the Journal of Clinical Endocrinology and Metabolism demonstrated that even replacement-dose GH in GHD adults increased fasting glucose by approximately 0.3 mmol/L and HbA1c by 0.12% over 12 months 7. At bodybuilding-range doses (4 to 10 IU daily, far exceeding the 0.2 to 0.8 mg/day therapeutic window), insulin resistance can become clinically significant.

The FDA's Position

The FDA issued a safety communication in 2012 reaffirming that HGH distribution for off-label anti-aging or performance use is illegal under the Food, Drug, and Cosmetic Act 8. Prescribing HGH outside of FDA-approved indications exposes both physician and patient to legal and clinical risk.

Nandrolone Decanoate: The "Deca" in the Stack

Nandrolone decanoate (brand name Deca-Durabolin) is a 19-nortestosterone derivative and Schedule III controlled substance. Its only remaining FDA-approved indication is anemia associated with chronic renal failure.

Anabolic-to-Androgenic Ratio

Nandrolone has an anabolic-to-androgenic ratio of approximately 125:37, making it a more potent tissue-builder relative to its androgenic effects compared to testosterone (100:100). This pharmacologic profile explains its historical popularity in bodybuilding. A 1999 randomized trial by Johansen et al. Showed that nandrolone decanoate at 100 mg weekly for 24 weeks increased lean body mass by 3.1 kg in hemodialysis patients, with minimal virilizing effects in men 9.

Joint and Collagen Effects

One reason athletes gravitate toward nandrolone is its reported effect on joint comfort. A 2000 study in the British Journal of Sports Medicine found that nandrolone increased type III collagen synthesis in tendons 10. This may explain anecdotal reports of reduced joint pain during nandrolone use, though controlled trial data in athletes remain sparse.

Cardiovascular and Hepatic Risks

Nandrolone suppresses HDL cholesterol aggressively. Hartgens et al. (2004) documented HDL reductions of 25 to 50% in male strength athletes using nandrolone over 8 to 14 weeks 11. The compound also suppresses endogenous testosterone production through hypothalamic-pituitary-gonadal axis feedback. Recovery of natural testosterone after nandrolone cessation can take months, and some users experience prolonged hypogonadism.

IGF-1: The Growth Factor Amplifier

Insulin-like growth factor 1 (IGF-1) mediates many of GH's anabolic effects. Exogenous IGF-1 (mecasermin, brand name Increlex) is FDA-approved only for children with severe primary IGF-1 deficiency who do not respond to GH 12.

Mechanism and Off-Label Use

IGF-1 binds the IGF-1 receptor on skeletal muscle, promoting protein synthesis and satellite cell proliferation. When stacked with GH, exogenous IGF-1 may amplify the anabolic signal beyond what either agent achieves alone. No randomized trials exist evaluating this combination in healthy adults for physique purposes.

Hypoglycemia Risk

The primary acute risk of exogenous IGF-1 is hypoglycemia. IGF-1 cross-reacts with the insulin receptor at high concentrations. The Increlex prescribing information carries a boxed warning for severe hypoglycemia, including seizures and loss of consciousness, particularly when administered without a meal 12. Using this compound outside medical supervision adds danger that cannot be overstated.

Long-Term Oncologic Concerns

Elevated circulating IGF-1 has been associated with increased risk of several malignancies. A 2014 individual participant data meta-analysis published in The Lancet Diabetes and Endocrinology found that men in the highest quintile of circulating IGF-1 had a 1.25-fold higher risk of prostate cancer compared to the lowest quintile (OR 1.25, 95% CI 1.07 to 1.46) 13. Exogenous administration pushes levels beyond the physiologic ceiling, and long-term oncologic consequences remain unknown.

The "Ancestral" Marketing vs. Pharmacologic Reality

Liver King built a brand around nine "ancestral tenets" (sleep, eat, move, shield, connect, cold, sun, fight, bond) and promoted raw organ meat consumption as the foundation of his physique. The revelation that a multi-compound pharmaceutical regimen was running in the background fundamentally undermined that narrative.

What Organ Meats Actually Provide

Beef liver is nutrient-dense, providing approximately 26,000 IU of vitamin A, 290 mcg of folate, and 60 mcg of vitamin B12 per 100 g 14. No peer-reviewed study demonstrates that organ meat consumption produces the degree of muscular hypertrophy Johnson displayed. Dr. Spencer Nadolsky, a board-certified obesity medicine physician, stated in a 2022 podcast: "You cannot eat your way to that level of muscularity at that body fat percentage past age 40 without pharmacologic assistance. The biology does not support it."

Consumer Protection Implications

A class-action lawsuit filed in early 2023 alleged that Johnson's promotion of his supplement line, Ancestral Supplements, constituted consumer fraud because reasonable consumers would interpret his physique as evidence that the supplements worked 15. The case underscored a broader public health concern: supplement brands endorsed by enhanced athletes can mislead consumers into purchasing products that cannot replicate the results shown in marketing materials.

What Legitimate TRT Looks Like

For men with confirmed hypogonadism (two morning total testosterone values below 300 ng/dL with symptoms), TRT follows a structured, monitored protocol that bears little resemblance to what Liver King described.

Diagnostic Criteria

The Endocrine Society requires at least two morning (before 10 AM) serum total testosterone measurements confirming levels below the lower limit of normal, combined with symptoms such as reduced libido, fatigue, or decreased lean mass 1. The American Urological Association (AUA) sets its diagnostic threshold at 300 ng/dL 16. Neither organization recommends testosterone for eugonadal men seeking physique enhancement.

Monitoring Protocol

Legitimate TRT requires baseline labs (total testosterone, free testosterone, LH, FSH, hematocrit, PSA, lipid panel) and follow-up at 3, 6, and 12 months, then annually. The Endocrine Society specifically recommends checking hematocrit within 3 to 6 months, discontinuing if it exceeds 54%, and monitoring bone density via DXA after 1 to 2 years in men with baseline osteoporosis 1. Supraphysiological protocols bypass this framework entirely.

Fertility Considerations

Exogenous testosterone suppresses spermatogenesis through negative feedback on gonadotropins. Men using high-dose testosterone often experience azoospermia within 3 to 6 months. The Endocrine Society guideline explicitly warns against TRT in men actively trying to conceive 1. Compounds like nandrolone add a second layer of gonadotropin suppression.

Risks of Unsupervised Multi-Compound Protocols

The combination of testosterone, HGH, nandrolone, and IGF-1 creates overlapping toxicity profiles. Each drug's adverse effects may compound the others.

Metabolic Burden

Testosterone and nandrolone both worsen lipid profiles by lowering HDL and, in some cases, raising LDL. HGH and IGF-1 both impair glucose homeostasis. Running all four simultaneously creates a metabolic environment favoring dyslipidemia, insulin resistance, and accelerated atherosclerosis. No clinical trial has evaluated the safety of combining all four agents in any population.

Cardiac Remodeling

Anabolic steroids promote left ventricular hypertrophy through direct androgen receptor activation in cardiomyocytes. Baggish et al. (2010) used cardiac MRI to demonstrate that long-term anabolic steroid users had significantly greater left ventricular mass index (mean 98 g/m² vs. 78 g/m²) and reduced ejection fraction compared to non-using weightlifters 5. Adding GH, which also promotes cardiac hypertrophy via IGF-1 signaling, may accelerate this remodeling.

Psychological Effects

Supraphysiological testosterone is associated with mood disturbances, irritability, and in rare cases aggression. A 2000 placebo-controlled crossover study by Pope et al. Found that 600 mg/week of testosterone cypionate produced hypomanic or manic symptoms in 16% of participants, including two cases severe enough to require drug discontinuation 17. Nandrolone has independently been linked to depressive symptoms during and after use.

The Bottom Line for Patients Considering TRT

Any man considering testosterone therapy should start with a proper diagnostic workup, not a social media influencer's supplement stack. Testosterone replacement at physiologic doses, prescribed for confirmed hypogonadism and monitored with regular lab work, has a favorable risk-benefit profile supported by the TRAVERSE trial and Endocrine Society guidelines. The protocol Liver King admitted to using is not TRT. It is a polypharmacy regimen with no supporting safety data in healthy adults, carrying measurable risks to cardiovascular, metabolic, hepatic, and reproductive health.